Evidence map›Paper›PMID 33891157›Full record

ArticleAmino acids2021

C-terminus amidation influences biological activity and membrane interaction of maculatin 1.1.

Shiying Zhu, Wenyi Li, Neil O'Brien-Simpson, Frances Separovic, Marc-Antoine Sani

Abstract read
PubMed Publisher
In one paragraph

Article in Amino acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Progressive Design of a Ranatuerin-2 Peptide fromAntibiotics (Basel, Switzerland) · 2023
    Article
  12. Oreoch-1: A Peptide fromPathogens (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shiying ZhuSchool of Chemistry, Bio21 Institute, University of Melbourne, Melbourne, VIC, 3010, Australia.ORCID http://orcid.org/0000-0001-9906-8424
Wenyi LiMelbourne Dental School and Bio21 Institute, University of Melbourne, Melbourne, VIC, 3010, Australia.ORCID http://orcid.org/0000-0003-3584-0301
Neil O'Brien-SimpsonMelbourne Dental School and Bio21 Institute, University of Melbourne, Melbourne, VIC, 3010, Australia.
Frances SeparovicSchool of Chemistry, Bio21 Institute, University of Melbourne, Melbourne, VIC, 3010, Australia.ORCID http://orcid.org/0000-0002-6484-2763
Marc-Antoine SaniSchool of Chemistry, Bio21 Institute, University of Melbourne, Melbourne, VIC, 3010, Australia. msani@unimelb.edu.au.ORCID http://orcid.org/0000-0003-3284-2176
The University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cationic antimicrobial peptides have been investigated for their potential use in combating infections by targeting the cell membrane of microbes. Their unique chemical structure has been investigated to understand their mode of action and optimize their dose-response by rationale design. One common feature among cationic AMPs is an amidated C-terminus that provides greater stability against in vivo degradation. This chemical modification also likely modulates the interaction with the cell membrane of bacteria yet few studies have been performed comparing the effect of the capping groups. We used maculatin 1.1 (Mac1) to assess the role of the capping groups in modulating the peptide bacterial efficiency, stability and interactions with lipid membranes. Circular dichroism results showed that C-terminus amidation maintains the structural stability of the peptide (α-helix) in contact with micelles. Dye leakage experiments revealed that amidation of the C-terminus resulted in higher membrane disruptive ability while bacteria and cell viability assays revealed that the amidated form displayed higher antibacterial ability and cytotoxicity compared to the acidic form of Mac1. Furthermore,

Indexed as

Amphibian ProteinsAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAnuraCell MembraneEscherichia coliLipid BilayersMicrobial ViabilityStaphylococcus aureusAmphibian ProteinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesLipid Bilayersmaculatin-1.1 protein, LitoriaAntimicrobial peptideCircular dichroismDye leakageMembranePhospholipid bilayerSolid-state NMR

Identifiers

PMID33891157
OpenAlexW3155906636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.